NasdaqGS - Nasdaq Real Time Price USD

Surgery Partners, Inc. (SGRY)

Compare
22.93
-0.61
(-2.59%)
As of 3:00:39 PM EDT. Market Open.
Loading Chart for SGRY
  • Previous Close 23.54
  • Open 22.95
  • Bid 16.78 x 200
  • Ask 28.72 x 200
  • Day's Range 22.25 - 23.27
  • 52 Week Range 19.50 - 33.97
  • Volume 845,399
  • Avg. Volume 1,282,170
  • Market Cap (intraday) 2.926B
  • Beta (5Y Monthly) 2.40
  • PE Ratio (TTM) --
  • EPS (TTM) -1.33
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 31.91

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

15,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

View More

Performance Overview: SGRY

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SGRY
8.31%
S&P 500 (^GSPC)
7.61%

1-Year Return

SGRY
16.59%
S&P 500 (^GSPC)
4.27%

3-Year Return

SGRY
58.63%
S&P 500 (^GSPC)
19.54%

5-Year Return

SGRY
377.71%
S&P 500 (^GSPC)
118.35%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    3.00B

  • Enterprise Value

    6.44B

  • Trailing P/E

    --

  • Forward P/E

    27.86

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.95

  • Price/Book (mrq)

    1.68

  • Enterprise Value/Revenue

    2.07

  • Enterprise Value/EBITDA

    12.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.40%

  • Return on Assets (ttm)

    4.01%

  • Return on Equity (ttm)

    0.36%

  • Revenue (ttm)

    3.11B

  • Net Income Avi to Common (ttm)

    -168.1M

  • Diluted EPS (ttm)

    -1.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    269.5M

  • Total Debt/Equity (mrq)

    102.14%

  • Levered Free Cash Flow (ttm)

    181.48M

Research Analysis: SGRY

View More

Company Insights: SGRY

Research Reports: SGRY

View More

People Also Watch